Innovative Eyewear, Inc. Announces New ReebokĀ® Smart Eyewear for Gym and Indoor Sports

Innovative Eyewear, Inc. (“Innovative Eyewear” or the “Company”) (NASDAQ: LUCY; LUCYW), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica®brands, is pleased to announce that it has launched two new, light-adaptive sport smartglasses in its cutting-edge Reebok Powered by Lucyd Smart Eyewear collection. These new variants of the Octane […]

/U P D A T E — Target Corporation/

In the news release, Attention Target Shoppers: Kris K.'s Top Tips to Win the Final Days of Holiday Shopping, issued Dec. 11, 2025 by Target Corporation over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Attention Target Shoppers: Kris

UC Davis School of Veterinary Medicine Adopts ScribbleVet for Veterinary Facilities, Students

ScribbleVet, an AI-powered scribe used by thousands of veterinarians, and UC Davis School of Veterinary Medicine, the number-one-ranked veterinary school in the United States, announced that the university has adopted ScribbleVet's veterinary AI scribe solution for use across its veterinary clinical facilities. UC Davis selected ScribbleVet for its accuracy, ease of use, and ability to

JHX INVESTOR NOTICE: James Hardie Industries Stock Dropped 34% on Destocking Issues and CFO Departure; Contact BFA Law about the Pending Securities Class Action

JHX INVESTOR NOTICE: James Hardie Industries Stock Dropped 34% on Destocking Issues and CFO Departure; Contact BFA Law about the Pending Securities Class Action GlobeNewswire December 11, 2025 NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against

TripleLift Closes a Breakthrough 2025 with Global Expansion, Creative Innovation and Strategic Partnerships Across CTV, Retail Media, and Addressability

TripleLift, the leading Creative SSP, is celebrating a milestone year defined by global expansion, accelerated product innovation and partnership momentum across CTV, retail media and programmatic addressability. The company advanced its position as the creative engine of programmatic advertising, delivering more relevant and performance driven ad experiences for advertisers and publishers around the world. https://mma.prnewswire.com/media/2439661/TripleLift_Branding_Logo__Final_logos_Full_lockup_Full_Colour__8_Logo.jpg

Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

(NASDAQ:CVKD), Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HIT It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing it from related compounds. Orphan Drug and Fast Track designations from the FDA PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) —

Survey: Nearly 4 in 10 Professionals Plan to Search for a New Job in 2026

— Robert Half research reveals the factors influencing job search plans, plus common pain points — New Job Search Strategies Guide provides a playbook for workers looking to change roles As we look ahead to 2026, new research from talent solutions and business consulting firm Robert Half shows that some professionals are putting a new

TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode’s Phase 1 trial

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) and Quantum Leap Healthcare Collaborative (“Quantum Leap”) today announce anew collaboration to evaluate TransCode's lead therapeutic candidate TTX-MC138 as part of the Quantum Leap PRE-I-SPY clinical trial platform. https://mma.prnewswire.com/media/2583692/TransCode_Logo.jpg The PRE-I-SPY program will incorporate TTX-MC138 in a Phase 2a dose-expansion clinical trial enrolling up to 45 patients with colorectal cancer

ALLEGRIA THERAPEUTICS SECURES USD 5.1 MILLION SEED EXTENSION FINANCING

Allegria Therapeutics (ALLEGRIA), a Swiss biotech company redefining the treatment landscape of therapeutics for mast cell-mediated diseases, announced today the successful completion of a USD 5.1 million seed extension financing. https://mma.prnewswire.com/media/2842790/Allegria_Therapeutics_Logo.jpg The financing round was led byALK Abelló, with participation of HighLight Capital (HLC), Lichtsteiner Foundation and co-founding investor Forty51 Ventures. The investment sets the

Tanishq Expands American Presence with Eighth U.S. Store in Tysons, Virginia

Tanishq, India's most trusted fine jewelry brand, has expanded its U.S. presence with the opening of its eighth store in Tysons Corner. Located at 8065 Leesburg Pike, Suite 120, the 5,500 sq. ft. showroom opened on August 8 and celebrated its grand opening on December 2. https://mma.prnewswire.com/media/2842125/Tanishq_USA_Tanishq_celebrates_the_grand_opening_of_its_newest_US_store_at_Tysons_Corner.jpg The event featured a ceremonial lamp lighting, ribbon

Scroll to Top